The revenue stands at ₹1,625.96 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.37 per cent from ₹1,421.64 crore. This corresponds to a year-on-year *(YoY) growth of 24.82 per cent.
Operating Profit stands at ₹423.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.04 per cent from ₹333.41 crore. This corresponds to a year-on-year *(YoY) growth of 20.56 per cent.
PBDT stands at ₹491.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.18 per cent from ₹392.48 crore. This corresponds to a year-on-year *(YoY) growth of 31.92 per cent.
Profit Before Tax stands at ₹446.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.72 per cent from ₹347.11 crore. This corresponds to a year-on-year *(YoY) growth of 34.93 per cent.
Net Profit stands at ₹334.22 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.32 per cent from ₹266.70 crore. This represents a 30.89 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | 1.19% | -0.76% | 4.08% | 13.80% | 20.56% | 31.74% |
| Anthem Bioscienc | 1.18% | 1.24% | 11.39% | 7.24% | 24.25% | 11.56% |
| Ipca Labs. | 0.41% | 0.79% | -2.84% | 13.28% | 21.76% | 29.88% |
| Glaxosmi. Pharma | 0.39% | -2.41% | 6.47% | 6.45% | -1.02% | -3.54% |
| Gland Pharma | -0.65% | 0.90% | 4.87% | 35.43% | 38.05% | 34.29% |
| Emcure Pharma | 2.12% | 0.54% | 9.20% | 17.79% | 30.70% | 42.41% |
| Wockhardt | 2.31% | -0.31% | 11.55% | 24.08% | 41.44% | 38.22% |
Chairman & Non Executive Dir. : Mannalal B Agrawal
Vice Chairman & Executive Dire : Madhusudan B Agrawal
ED / MD / Promoter : Yogesh Agrawal
ED / WTD / Joint MD / Promoter : Rajesh M Agrawal
Independent Non Exe. Director : David Rasquinha
Independent Non Exe. Director : Rajesh Shashikant Dalal
Independent Non Exe. Director : Medha Joshi
Independent Non Exe. Director : Simi Thapar
Senior Vice President & CS : Gaurang Shah